Stay updated on Dupilumab in Bullous Pemphigoid Adults Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Bullous Pemphigoid Adults Clinical Trial page.

Latest updates to the Dupilumab in Bullous Pemphigoid Adults Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision: v3.6.3 is now shown, replacing the previous v3.6.2. This reflects a small, backend/maintenance update to the page.SummaryDifference0.0%

- Check15 days agoChange DetectedRevision: v3.6.2 is now shown on the page, replacing the previous v3.6.0. This indicates the page content has been updated to a newer version.SummaryDifference0.0%

- Check22 days agoChange DetectedNew metadata references have been added, including an expanded access record and a plain language summary link, while several date entries were removed from the study record. These updates adjust ancillary information and external resources without changing the study’s core details.SummaryDifference0.4%

- Check29 days agoChange DetectedThe page adds a recruitment notice 'No longer looking for participants' and introduces new help sections (How to Read a Study Record, Common Questions, How to Join a Study). It also standardizes the Intervention/Treatment header and updates revision notes from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check37 days agoChange DetectedRevision tag on the page changed from v3.5.4 to v3.5.5, reflecting a minor update to the page version.SummaryDifference0.0%

- Check58 days agoChange DetectedAdded a new revision entry v3.5.4 and removed the prior entry v3.5.3 from the page's revision history.SummaryDifference0.0%

Stay in the know with updates to Dupilumab in Bullous Pemphigoid Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Bullous Pemphigoid Adults Clinical Trial page.